The Cigna Group posted strong Q3 2024 results, yet CI stock is down nearly 20% from its 52-week high. See why this may ...
As Cigna and Humana pick back up on the potential for a megamerger, executives will be keeping a close eye on the outcomes of ...
Three independent pharmacies have filed lawsuits accusing GoodRx, which markets a prescription drug discount card, of ...
The company's Evernorth business, which includes its PBM services, has shown particular strength, contributing significantly to overall performance. Looking ahead to 2025, Cigna's management has ...
In the third quarter of 2024, Cigna reported solid financial results, reaffirming its full-year guidance for 2024 with an EPS of at least $28.40. The company's Evernorth business, which includes its ...
GoodRx (NASDAQ:GDRX) is facing lawsuits from several independent pharmacies who are accusing the company of working with ...
The Rio-based network of independent pharmacies blames drug industry intermediaries known as pharmacy benefit managers.